Literature DB >> 6813499

1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties.

M R Schneider, E von Angerer, H Schönenberger, R T Michel, H P Fortmeyer.   

Abstract

1,1,2-Triphenylbut-1-enes, which are substituted with acetoxy groups on one, two, or three aromatic rings in the para and/or meta positions, were synthesized. The identity of the occurring E and Z isomers were established by 1H NMR spectroscopy. A study on structure-activity relationships was carried out with regard to estradiol receptor affinity and to inhibiting effects on the growth of a postmenopausal human mammary carcinoma implanted in nude mice. The para-substituted compounds generally exhibited a higher receptor affinity and a better antitumor activity than the corresponding meta-substituted ones. The E isomers were superior to the respective Z isomers in those two properties. The tumor-inhibiting effect of the mono- and disubstituted compounds was better than that of the trisubstituted ones. Except for the trisubstituted compounds, they all show a good correlation between estradiol receptor affinity and antitumor activity. One of the compounds was also tested on the 9,10-dimethylbenz[a]-anthracene-induced, hormone-dependent mammary carcinoma of the Sprague-Dawley rat, and the results corresponded to those obtained in the xenograft tumor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813499     DOI: 10.1021/jm00351a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.

Authors:  V C Jordan; R Koch; S Mittal; M R Schneider
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

2.  Cytotoxic esters of 1,1-bis-(4-hydroxyphenyl)-2-phenyl-but-1-ene with selective antitumor activity against estrogen receptor-containing mammary tumors.

Authors:  M L Schuderer; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Acetoxy substituted 1,1,2-triphenylbut-1-enes: estrogenic, antiestrogenic and mammary tumor inhibiting activity.

Authors:  M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

4.  Chlorocarbamate-mustard-linked 1,1,2-triphenylbut-1-enes with a selective antitumor activity on mammary tumors containing estrogen receptors.

Authors:  M R Schneider; M L Schuderer
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate.

Authors:  M R Schneider; E von Angerer; J Prekajac; W P Brade
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity.

Authors:  M R Schneider; R W Hartmann; F Sinowatz; W Amselgruber
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites.

Authors:  Nicolli Bellotti de Souza; Anna Caroline Campos Aguiar; Alane Cabral de Oliveira; Siden Top; Pascal Pigeon; Gérard Jaouen; Marilia Oliveira Fonseca Goulart; Antoniana Ursine Krettli
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-11-24       Impact factor: 2.743

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.